12 Week Patient Study in Neovascular Age-related Macular Degeneration (AMD)
Status:
Terminated
Trial end date:
2012-04-16
Target enrollment:
Participant gender:
Summary
The purpose of this 12 week, open-label study is to investigate the safety and efficacy of a
single dose regimen of pazopanib eye drop for neovascular AMD.